Dna Vaccines Co-Expressing Containing Hsp70 and Gp5/M Protein of Porcine Reproductive and Respiratory Syndrome Virus (prrsv) Display Enhanced Immunogenicity
Zuo Lan,Yan Qi-Gui,Lei Yan,Wang Xu,Feng Ying-Chun,Chen Yu,Ren Yu-Peng,Wan Li,Li Shuang-Jiang,Liu Bing
DOI: https://doi.org/10.4028/www.scientific.net/amm.195-196.452
2012-01-01
Applied Mechanics and Materials
Abstract:Construction of Eukaryotic recombinant expression Vector pCI-ORF5-ORF6/ pCI-ORF5-ORF6B-Hsp70 Containing Hsp70 and PRRSV GP5/M (encoded by ORF5 and ORF6 genes), and to study its immune effect. After ifentified by enzyme analysis and nucleotide sequencing test,the repression vector plasmid was transfected into COS-7 cells. The transient expression protein was detected by indirect immunofluorescence assay (IFA) and Western-blotting. The immunogenicities of this DNA vaccine constructs were firstly investigated in a mouse moder. IFN-γ, IL-4 of cytokine, and the spleen T-lymphocyte subgroup quantity (CD4+/CD8+) were detected. The result shows that the recombinant plasmid pCI-ORF5-ORF6-Hsp70 could induce higher response of cellular immune responses and specific hummune responses in mouse, providing the clinical basic data and theoretical basis for success of the DNA vaccine development.